MedinCell Partner Teva Delivers Unprecedented Antipsychotic Data
A positive efficacy, safety, and tolerability profile has emerged from Medincell and Teva’s Phase 3 SOLARIS trial evaluating Olanzapine...
Introducing Ultherapy PRIME: Revolutionizing Non-Surgical Skin Lifting
Ultherapy PRIME, a groundbreaking ultrasound technology, significantly advances noninvasive skin treatments. With real-time imaging, it delivers personalized and long-lasting...
Unveiling the Surging Growth of Virtual Clinical Trials
The Virtual Clinical Trials (VCT) market has surged to an estimated USD 2.64 billion in 2023, projected to reach...
FDA’s Diversity in Clinical Trials Plan: Why It Fails to Address Key Barriers for Underrepresented Communities
This is an AI-Generated podcast. This podcast discusses the FDA’s recent guidance on inclusion and diversity in clinical trials...
Diversity in Clinical Trials: How the FDA’s Guidelines Miss the Mark on Inclusion
Today, we had the privilege of sitting with Mumbi Kairu from The Pamoja Research Institute in Anaheim, California. Mumbi...
Is Big Pharma in Decline?
This is an AI-Generated podcast. The pharmaceutical industry, often viewed as a pillar of global innovation, is facing a...
AngioDynamics Initiates Landmark Trial for Pulmonary Embolism Treatment
AngioDynamics has initiated a comprehensive study to evaluate the efficacy and safety of the AlphaVac Mechanical Aspiration Thrombectomy System...
Unveiling the Transformative Power of Takeda’s Narcolepsy Treatment: Clinical Trial Triumphs at Sleep Europe 2024
Takeda will showcase data from its Phase 2b trials and long-term extension study of TAK-861, an investigational orexin receptor...
Cybin Announces Groundbreaking Clinical Progress, Unveiling Transformative Therapies for Mental Health
Cybin Inc., a clinical-stage biotech company, is advancing its clinical programs for neuropsychiatric disorders. The company’s lead programs, CYB003...
Cybin Completes Announced Share Consolidation
Toronto-based Cybin Inc., a clinical-stage neuropsychiatry company focused on developing novel treatments for mental health conditions, has consolidated its...